Literature DB >> 19998208

Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).

A von Herbay1, C Vogt, J Westendorff, D Häussinger, M Gregor.   

Abstract

PURPOSE: The aim of the study was to characterize SonoVue enhancement in hepatocellular carcinoma in correlation to both lesion diameter and histological differentiation of the lesion.
MATERIALS AND METHODS: In a prospective study 130 patients (72 male, 58 female, 62 +/- 10 years) with HCC lesions detected by B-mode sonography were examined. After injection of 1.2 - 2.4 ml SonoVue, HCC lesions were examined continuously for up to 5 min using "low MI" sonography.
RESULTS: Arterial hypervascularization was found in 72 % of the HCC lesions without correlation to the lesion diameter or histological grading, when analyzed for the total group. However, the analysis of the G 1 subgroup showed significant correlation between lesion diameter and arterial hypervascularization. Arterial hypervascularization was found in 95 % of the G 1 lesions > 3 cm but in only 43 % of the G 1 lesions < 3 cm (p < 0.001). In contrast, analysis of the remaining HCC lesions (without G 1) showed arterial hypervascularization in 69 % of the lesions < 3 cm and in 72 % of the lesions > 3 cm (n. s.) without correlation to the diameter. In the late phase in the G 1 subgroup, hypoechoic demarcation was found in 95 % of the G 1 lesions > 3 cm, but in only 64 % of the G 1 lesions < 3 cm (p < 0.001). In contrast, in the less differentiated HCC lesions (without G 1), hypoechoic demarcation was found in 91 % (HCC > 3 cm) and in 82 % (HCC < 3 cm) of the lesions (n. s.).
CONCLUSION: In well-differentiated HCCs (G1) hyperechoic enhancement in the arterial phase and hypoechoic demarcation in the late phase correlate to the diameter. Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19998208     DOI: 10.1055/s-0028-1109745

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  7 in total

1.  Contrast ultrasound in hepatocellular carcinoma at a tertiary liver center: First Indian experience.

Authors:  Shalini Thapar Laroia; Simranjeet Singh Bawa; Deepak Jain; Amar Mukund; Shiv Sarin
Journal:  World J Radiol       Date:  2013-06-28

2.  Contrast-enhanced ultrasound of hepatocellular carcinoma: correlation between enhancement pattern and cellular differentiation on histopathlogy.

Authors:  F Loria; G Loria; S Basile; G Crea; D Randazzo; L Frosina
Journal:  Updates Surg       Date:  2012-10-07

3.  Tumor size-based validation of contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) 2017 for hepatocellular carcinoma characterizing.

Authors:  Jia-Min Pan; Wei Chen; Yan-Ling Zheng; Mei-Qing Cheng; Dan Zeng; Hui Huang; Yang Huang; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Hang-Tong Hu; Li-Da Chen; Wei Wang
Journal:  Br J Radiol       Date:  2021-10-01       Impact factor: 3.629

4.  Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Guang-Jian Liu; Wei Wang; Ming-De Lu; Xiao-Yan Xie; Hui-Xiong Xu; Zuo-Feng Xu; Li-Da Chen; Zhu Wang; Jin-Yu Liang; Yang Huang; Wei Li; Jin-Ya Liu
Journal:  Liver Cancer       Date:  2015-10-21       Impact factor: 11.740

5.  Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.

Authors:  Janine Rennert; Isabel Wiesinger; Andreas Schicho; Lukas Philip Beyer; Philipp Wiggermann; Christian Stroszczynski; Ernst Michael Jung
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

6.  Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.

Authors:  Dan Yang; Rui Li; Xiao-Hang Zhang; Chun-Lin Tang; Kuan-Sheng Ma; De-Yu Guo; Xiao-Chu Yan
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

7.  Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.

Authors:  D Strobel; E-M Jung; M Ziesch; M Praktiknjo; A Link; C F Dietrich; C Klinger; M Schultheiß; D Jesper; B Schellhaas
Journal:  Eur Radiol       Date:  2021-04-15       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.